TORRENT PHARMACEUTICALS L financial statements, including revenue, expenses, profit, and loss

The total revenue of TORNTPHARM for the last quarter is 28.89 B INR, and it's 1.05% higher compared to the previous quarter. The net income of Q2 24 is 4.53 B INR.